Employers that sponsor group health plans continue to grapple with the fallout of last year’s decision in Dobbs that overturned Roe v. Wade…
This includes litigation involving mifepristone, an abortion drug.
As has been widely reported, the FDA removed the in-person dispensing requirement relating to the drug.
This led to some employers adding coverage